PHOTREXA VISCOUS IN DEXTRAN 20%/PHOTREXA (riboflavin 5'-phosphate sodium) · GLAUKOS
In disorders requiring parenteral administration of vitamins, i.e. pre- and post-operative treatment, when requirements are increased as in fever, severe burns, increased metabolism, pregnancy, gastrointestinal disorders interfering with intake or absorption of vitamins, prolonged or wasting diseases, alcoholism and where other deficiencies exist.
Details
- Status
- Prescription
- First Approved
- 2016-04-15
- Routes
- OPHTHALMIC
- Dosage Forms
- SOLUTION/DROPS
PHOTREXA VISCOUS IN DEXTRAN 20%/PHOTREXA Approval History
What PHOTREXA VISCOUS IN DEXTRAN 20%/PHOTREXA Treats
4 indicationsPHOTREXA VISCOUS IN DEXTRAN 20%/PHOTREXA is approved for 4 conditions since its original approval in 2016. These indications span multiple therapeutic areas including oncology, immunology, and more.
- Fever
- Burns
- Gastrointestinal Disorder
- Alcoholism
PHOTREXA VISCOUS IN DEXTRAN 20%/PHOTREXA Competitive Set
ProThree rings of competition based on shared molecular targets and treated indications.
Indication competitors
Same indication, different mechanism — what else might this patient receive?
Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.
Drugs Similar to PHOTREXA VISCOUS IN DEXTRAN 20%/PHOTREXA
3 of 20FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
PHOTREXA VISCOUS IN DEXTRAN 20%/PHOTREXA FDA Label Details
Indications & Usage
FDA Label (PDF)In disorders requiring parenteral administration of vitamins, i.e. pre- and post-operative treatment, when requirements are increased as in fever, severe burns, increased metabolism, pregnancy, gastrointestinal disorders interfering with intake or absorption of vitamins, prolonged or wasting diseases, alcoholism and where other deficiencies exist.
Track PHOTREXA VISCOUS IN DEXTRAN 20%/PHOTREXA with TheraRadar Pro
Watchlist alerts, full database access, CSV exports across 14,000+ drugs.
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.